Alex Adams
Leadership Fellow
Recent publications
-
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.
Journal article
Adams A. et al, (2022), Gut
-
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.
Journal article
McGregor CG. et al, (2021), Gut, 70, 2398 - 2400
-
Analysis of systemic epigenetic alterations in inflammatory bowel disease: defining geographical, genetic, and immune-inflammatory influences on the circulating methylome
Preprint
Kalla R. et al, (2021)
-
Discovery of a simple two-gene expression biomarker in whole blood predictive of the need for treatment escalation in inflammatory bowel disease
Preprint
Nowak J. et al, (2021)
-
Optimising Early Management of Acute Severe Ulcerative Colitis in the Biologics Era: Admission Model for Intensification of Therapy in Acute Severe Colitis (ADMIT–ASC)
Preprint
Adams A. et al, (2021)